GO:0038194 thyroid-stimulating hormone signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0038194 (thyroid-stimulating hormone signaling pathway) is a G protein-coupled receptor signaling pathway initiated by TSH binding to TSHR and ending with regulation of downstream cellular processes such as transcription.
• TSHR signaling is essential for thyroid gland development and differentiation, as shown by knockout and knockin mouse models.
• Constitutive activation of TSHR signaling, e.g. the D633H mutation, drives MAPK signaling and papillary thyroid carcinoma in knockin mice.
• TSH/TSHR signaling extends beyond the thyroid: it promotes CD8+ T cell exhaustion and immune evasion in colorectal carcinoma and regulates hepatic gluconeogenesis via CRTC2.
• Deficient TSH/TSHR signaling causes central hypothyroidism-associated intestinal dysplasia, highlighting its role in gut homeostasis.
• The pathway is a target for research in autoimmune thyroiditis, thyroid cancer, and metabolic disorders, with myoinositol showing modulatory effects [3,4].
Description
The thyroid-stimulating hormone signaling pathway (GO:0038194) is a biological process in which thyroid-stimulating hormone (TSH, thyrotropin) binds to its receptor (TSHR) on the cell surface, activating a G protein-coupled receptor signaling cascade that ultimately regulates downstream cellular processes, including transcription. This pathway is central to thyroid physiology, controlling the development, differentiation, and function of the thyroid gland. Beyond the thyroid, TSH/TSHR signaling has been implicated in diverse tissues, such as the liver, intestine, and immune system, underscoring its broad biological significance [1,7,8]. Researchers study this pathway to understand thyroid-related diseases, including autoimmune thyroiditis and thyroid cancer, as well as its emerging roles in cancer immunity and metabolic regulation [2,3,4]. The pathway's complexity, involving receptor multimerization, cleavage, and multiple signaling branches, makes it a rich subject for molecular and genetic investigations.
thyroid-stimulating hormone signaling pathway At A Glance
| GO ID | GO:0038194 |
|---|---|
| GO term | thyroid-stimulating hormone signaling pathway |
| Ontology | biological_process |
| Synonym | thyrotropin signaling pathway; TSH signaling pathway |
| Major function | G protein-coupled receptor signaling initiated by TSH binding to TSHR, regulating transcription and other cellular processes |
| Key receptor | TSHR (thyroid-stimulating hormone receptor) |
| Key ligand | TSH (thyroid-stimulating hormone, thyrotropin) |
| Downstream effectors | G proteins, MAPK, CRTC2, and other signaling intermediates |
| Physiological roles | Thyroid development and differentiation, hepatic gluconeogenesis, intestinal homeostasis, immune regulation |
What Is GO:0038194?
According to the Gene Ontology, GO:0038194 (thyroid-stimulating hormone signaling pathway) is defined as a G protein-coupled receptor signaling pathway initiated by thyroid-stimulating hormone (thyrotropin) binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. This definition captures the essential steps: ligand binding, receptor activation, intracellular signal transduction, and ultimate cellular response. The pathway is synonymous with thyrotropin signaling pathway and TSH signaling pathway.
Why Is thyroid-stimulating hormone signaling pathway Important in Cell Biology?
The thyroid-stimulating hormone signaling pathway is critically important because it governs fundamental aspects of thyroid biology and systemic metabolism. Disruption of this pathway leads to thyroid dysfunction, including hypothyroidism and hyperthyroidism, and is implicated in autoimmune thyroiditis and thyroid cancer [3,4]. Moreover, its role in immune evasion in colorectal carcinoma and in central hypothyroidism-associated intestinal dysplasia highlights its broader impact on human health [1,8]. Understanding this pathway is therefore essential for developing targeted therapies for thyroid disorders, metabolic diseases, and certain cancers.
• Essential for thyroid gland development and differentiation, as demonstrated by TSHR knockout models.
• Constitutive activation of TSHR (e.g., D633H mutation) induces MAPK signaling and papillary thyroid carcinoma in knockin mice.
• TSH/TSHR signaling promotes CD8+ T cell exhaustion and immune evasion in colorectal carcinoma.
• Regulates hepatic gluconeogenesis through CRTC2, linking thyroid function to glucose metabolism.
• Deficiency in TSH/TSHR signaling causes central hypothyroidism-associated intestinal dysplasia.
• Implicated in autoimmune thyroiditis, where myoinositol may modulate signaling.
• BRAF-induced senescence and TSH signaling interact in papillary thyroid carcinoma progression.
• Receptor multimerization, cleavage, and antibody interactions modulate signaling in disease.
• Provides a model for studying G protein-coupled receptor signaling mechanisms.
• Potential target for therapeutic intervention in thyroid cancer and metabolic disorders [2,7].
What Happens During thyroid-stimulating hormone signaling pathway?
Ligand Binding and Receptor Activation
In simple terms: TSH binds to its receptor on the cell surface, switching it on.
The pathway begins when thyroid-stimulating hormone (TSH) binds to the thyroid-stimulating hormone receptor (TSHR), a G protein-coupled receptor, on the surface of target cells. This binding induces conformational changes in TSHR, leading to its activation. TSHR can exist as multimers, and its cleavage and multimerization state influence signaling. In thyroid cells, this activation is a prerequisite for subsequent intracellular events that regulate thyroid function.
G Protein Activation and Second Messenger Production
In simple terms: The activated receptor turns on G proteins, which then produce messenger molecules inside the cell.
Upon activation, TSHR interacts with G proteins, primarily Gs, which stimulates adenylyl cyclase to produce cyclic AMP (cAMP). This second messenger activates protein kinase A (PKA), leading to phosphorylation of downstream targets. TSHR can also couple to other G proteins, such as Gq, activating phospholipase C and increasing intracellular calcium. The balance between these pathways determines the cellular response.
Downstream Signaling Cascades
In simple terms: The signal spreads through multiple molecular pathways, including MAPK and CRTC2.
Beyond cAMP/PKA, TSH/TSHR signaling activates mitogen-activated protein kinase (MAPK) cascades, which regulate gene expression and cell proliferation. In the liver, TSH increases hepatic gluconeogenesis via CRTC2, a transcriptional coactivator. These cascades integrate with other signaling networks to modulate diverse cellular outcomes, including metabolism, growth, and differentiation [2,7].
Regulation of Transcription and Cellular Responses
In simple terms: The signal reaches the nucleus and changes which genes are turned on or off.
The ultimate outcome of TSH/TSHR signaling is the regulation of transcription factors and gene expression. For example, in thyroid cells, this pathway controls the expression of genes required for thyroid hormone synthesis and secretion. In immune cells, TSH/TSHR signaling promotes CD8+ T cell exhaustion by altering transcriptional programs. In the intestine, deficient signaling leads to dysplasia, indicating its role in maintaining tissue homeostasis.
Feedback and Crosstalk
In simple terms: The pathway is fine-tuned by feedback loops and interactions with other signals.
TSH/TSHR signaling is subject to feedback regulation, including negative feedback by thyroid hormones. Additionally, crosstalk with other pathways, such as BRAF-induced senescence, influences disease progression. Myoinositol has been shown to modulate TSH signaling in autoimmune thyroiditis, suggesting additional regulatory inputs. These mechanisms ensure appropriate physiological responses and are often disrupted in disease.
Key Genes Involved in GO:0038194 thyroid-stimulating hormone signaling pathway
The following genes and proteins are key components or regulators of the thyroid-stimulating hormone signaling pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TSHR | Receptor for TSH; initiates signaling | Mutations cause thyroid disorders; target in cancer and autoimmune studies [2,6] |
| TSHB | Beta subunit of TSH; ligand for TSHR | Essential for TSH bioactivity; knockout models show hypothyroidism |
| GNAS | G protein alpha s; couples TSHR to adenylyl cyclase | Mutations in GNAS affect cAMP signaling and thyroid function |
| PRKACA | Catalytic subunit of PKA; mediates cAMP effects | Phosphorylates targets downstream of TSH signaling |
| MAPK1 | Extracellular signal-regulated kinase 2; MAPK pathway | Activated by TSHR mutants; drives proliferation in thyroid cancer |
| MAPK3 | Extracellular signal-regulated kinase 1; MAPK pathway | Contributes to MAPK signaling in thyroid carcinoma |
| CRTC2 | CREB-regulated transcription coactivator 2 | Mediates TSH-induced hepatic gluconeogenesis |
| BRAF | Serine/threonine kinase; MAPK pathway | Interacts with TSH signaling in papillary thyroid carcinoma |
| CD8A | Marker of cytotoxic T cells | TSH/TSHR signaling promotes CD8+ T cell exhaustion |
| PDCD1 | Programmed cell death 1; immune checkpoint | Upregulated in exhausted T cells in colorectal carcinoma |
| CTLA4 | Cytotoxic T-lymphocyte associated protein 4 | Immune checkpoint; may be influenced by TSH signaling |
| IL2 | Interleukin 2; T cell growth factor | T cell exhaustion involves altered cytokine signaling |
| TNF | Tumor necrosis factor; inflammatory cytokine | May be modulated in TSH-related immune responses |
| IFNG | Interferon gamma; immune response | Associated with T cell effector function in cancer |
| GNAQ | G protein alpha q; couples TSHR to PLC | Alternative G protein coupling for TSHR |
| PLCB1 | Phospholipase C beta 1; generates IP3 and DAG | Mediates calcium signaling downstream of TSHR |
| CREB1 | cAMP response element-binding protein | Transcription factor activated by PKA; regulates gene expression |
| SLC5A5 | Sodium-iodide symporter; thyroid hormone synthesis | Expression regulated by TSH/TSHR signaling |
How Is thyroid-stimulating hormone signaling pathway Regulated?
The thyroid-stimulating hormone signaling pathway is tightly regulated at multiple levels. Receptor availability and sensitivity are modulated by TSHR multimerization, cleavage, and interaction with autoantibodies. Negative feedback by thyroid hormones reduces TSH secretion, thereby dampening pathway activity. Intracellularly, signaling is regulated by desensitization mechanisms, including receptor phosphorylation and arrestin recruitment. Crosstalk with other pathways, such as MAPK and PI3K, fine-tunes the response. Additionally, myoinositol has been reported to modulate TSH signaling in autoimmune thyroiditis, suggesting nutritional or pharmacological regulation. In disease states, constitutive activation mutations, such as TSHR D633H, bypass normal regulation and drive tumorigenesis.
thyroid-stimulating hormone signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TSHR | Papillary thyroid carcinoma; autoimmune thyroiditis | Knockin mice with D633H mutation; KO mice [2,6] |
| BRAF | Papillary thyroid carcinoma progression | BRAF V600E knockin mice; senescence models |
| TSHB | Central hypothyroidism; intestinal dysplasia | TSHB knockout mice [5,8] |
| CRTC2 | Hepatic gluconeogenesis dysregulation | Liver-specific CRTC2 knockout mice |
| CD8A | T cell exhaustion in colorectal carcinoma | CD8+ T cell-specific TSHR knockout mice |
Thyroid Cancer
Constitutive activation of TSHR signaling, such as the D633H mutation, leads to sustained MAPK signaling and the development of papillary thyroid carcinoma in knockin mice. BRAF-induced senescence interacts with TSH signaling to influence tumor progression. These findings highlight the pathway as a driver of thyroid oncogenesis and a potential therapeutic target.
Autoimmune Thyroiditis
In autoimmune thyroiditis, TSH receptor antibodies can stimulate or block signaling, contributing to thyroid dysfunction. Myoinositol, a naturally occurring isomer of glucose, has been shown to modulate TSH signaling and may have beneficial effects in autoimmune thyroiditis. This suggests that the pathway is a key player in autoimmune thyroid disease.
Colorectal Carcinoma and Immune Evasion
Local TSH/TSHR signaling promotes CD8+ T cell exhaustion and immune evasion in colorectal carcinoma, indicating that the pathway can be co-opted by tumors to suppress anti-tumor immunity. This expands the relevance of TSH signaling beyond the thyroid to cancer immunology.
Central Hypothyroidism-Associated Intestinal Dysplasia
Thyroid hormone deprivation and TSH/TSHR signaling deficiency lead to central hypothyroidism-associated intestinal dysplasia, demonstrating a role for the pathway in gut development and homeostasis. This connection underscores the systemic importance of TSH signaling.
From thyroid-stimulating hormone signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Role of TSHR in thyroid development | TSHR knockout mouse |
| Constitutive TSHR activation in thyroid cancer | TSHR D633H knockin mouse |
| TSH signaling in hepatic gluconeogenesis | Liver-specific CRTC2 knockout or TSHR knockout |
| TSH/TSHR signaling in T cell exhaustion | CD8+ T cell-specific TSHR knockout in colorectal cancer models |
| TSH signaling in intestinal homeostasis | TSHR knockout or TSHB knockout mice |
| Receptor multimerization and cleavage | Tagged TSHR knock-in cell lines |
How to Study the thyroid-stimulating hormone signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Study TSHR or TSHB requirement in thyroid development |
| CRISPR knockin | Introduction of specific mutations | Model TSHR D633H in thyroid cancer |
| RNA-seq | Transcriptome changes | Identify TSH-regulated genes in thyroid cells |
| Proteomics | Protein expression and modifications | Map signaling networks downstream of TSHR |
| cAMP assay | Intracellular cAMP levels | Measure TSHR activation by TSH |
| Luciferase reporter | Transcription factor activity | Assess CREB-driven transcription |
| Western blot | Phosphorylated MAPK levels | Detect MAPK activation by TSHR mutants |
| Immunohistochemistry | Protein localization in tissues | Detect TSHR in colorectal carcinoma |
Genetic Knockout and Knockin Models
CRISPR/Cas9-mediated knockout of TSHR or TSHB in mice or cell lines allows researchers to study loss-of-function phenotypes, such as impaired thyroid development. Knockin of activating mutations, like TSHR D633H, recapitulates human disease and reveals oncogenic mechanisms. These models are essential for causal inference.
Transcriptomic and Proteomic Profiling
RNA sequencing (RNA-seq) and proteomics can identify genes and proteins whose expression is regulated by TSH/TSHR signaling. For example, transcriptomic analysis of thyroid cells treated with TSH reveals target genes involved in hormone synthesis. In immune cells, RNA-seq has been used to characterize T cell exhaustion programs induced by TSH/TSHR signaling.
Signaling Pathway Assays
cAMP accumulation assays, luciferase reporter assays for CREB activity, and Western blotting for phosphorylated MAPK are standard methods to measure TSH/TSHR signaling activation. These techniques allow quantification of pathway activity in response to ligands or mutations.
Imaging and Immunohistochemistry
Immunohistochemistry can localize TSHR and downstream effectors in tissues, such as thyroid or colorectal tumors. Fluorescence microscopy of tagged TSHR can reveal receptor trafficking and multimerization. These methods provide spatial context to signaling events.
How CRISPR Can Be Used to Study GO:0038194 thyroid-stimulating hormone signaling pathway
Knockout
CRISPR knockout of TSHR or TSHB is used to create loss-of-function models. For example, TSHR knockout mice exhibit impaired thyroid development and differentiation, demonstrating the pathway's essential role. In cell lines, knockout of TSHR abolishes TSH-induced cAMP production, allowing researchers to study downstream effects.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes, such as the D633H mutation in TSHR, which causes constitutive activation. This approach has been used to generate knockin mice that develop papillary thyroid carcinoma, linking the mutation to MAPK activation and tumorigenesis.
Knock-in
Knock-in of reporter genes or tags into the TSHR locus enables visualization and tracking of the receptor. Tagged TSHR knock-in cell lines help study receptor multimerization, cleavage, and trafficking, which are important for signaling regulation.
Overexpression
Overexpression of wild-type or mutant TSHR in cell lines can amplify signaling and facilitate biochemical analysis. For instance, overexpression of TSHR D633H in HEK293 cells leads to elevated cAMP and MAPK activation, providing a system to test inhibitors.
How EDITGENE Supports thyroid-stimulating hormone signaling pathway Research
Researchers studying thyroid-stimulating hormone signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway function or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for thyroid-stimulating hormone signaling pathway research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TSHR Knockout HEK293 Cell Line | EDJ-KQ1771 | Human | 7253 | Details Get a Quote |
| PAX8 Knockout HEK293 Cell Line | EDJ-KQ5430 | Human | 7849 | Details Get a Quote |
| PAX8 Knockout HCT 116 Cell Line | EDJ-KQ29908 | Human | 7849 | Details Get a Quote |
| TSHR Knockout HeLa Cell Line | EDJ-KQ54698 | Human | 7253 | Details Get a Quote |
| PAX8 Knockout HeLa Cell Line | EDJ-KQ54800 | Human | 7849 | Details Get a Quote |
| TSHR Knockout A-549 Cell Line | EDJ-KQ63185 | Human | 7253 | Details Get a Quote |
| PAX8 Knockout A-549 Cell Line | EDJ-KQ63292 | Human | 7849 | Details Get a Quote |
| TSHR Knockout HCT 116 Cell Line | EDJ-KQ71657 | Human | 7253 | Details Get a Quote |
| TSHR Knockout MOLP-8 Cell Line | EDC07700 | Human | 7253 | Details Get a Quote |
| TSHR Overexpression HEK293 Stable Cell Line | EDJ-GQ117 | Human | 7253 | Details Get a Quote |
Displaying Records 1 To 10 Of 10 Records
Frequently Asked Questions About thyroid-stimulating hormone signaling pathway
What is the thyroid-stimulating hormone signaling pathway?
It is a biological process (GO:0038194) where TSH binds to its receptor TSHR, activating a G protein-coupled signaling cascade that regulates transcription and other cellular responses.
What genes are involved in thyroid-stimulating hormone signaling pathway?
Key genes include TSHR, TSHB, GNAS, PRKACA, MAPK1, MAPK3, CRTC2, and BRAF, among others [2,5,6,7].
What diseases are associated with TSH signaling?
Diseases include thyroid cancer, autoimmune thyroiditis, colorectal carcinoma with immune evasion, and central hypothyroidism-associated intestinal dysplasia [1,2,3,8].
How is TSH signaling studied in the lab?
Common methods include CRISPR knockout/knockin models, cAMP assays, Western blotting for MAPK, RNA-seq, and immunohistochemistry [2,5,6].
What is the role of TSHR in thyroid cancer?
Activating mutations in TSHR, such as D633H, cause constitutive MAPK signaling and papillary thyroid carcinoma in knockin mice.
Can TSH signaling affect the immune system?
Yes, local TSH/TSHR signaling promotes CD8+ T cell exhaustion and immune evasion in colorectal carcinoma.
What is the connection between TSH and liver metabolism?
TSH increases hepatic gluconeogenesis via CRTC2, linking thyroid function to glucose metabolism.
How does TSH signaling affect the intestine?
Deficiency in TSH/TSHR signaling leads to central hypothyroidism-associated intestinal dysplasia.
What are the synonyms for thyroid-stimulating hormone signaling pathway?
Synonyms are thyrotropin signaling pathway and TSH signaling pathway.
What is the GO ID for thyroid-stimulating hormone signaling pathway?
The GO ID is GO:0038194.
Conclusion
The thyroid-stimulating hormone signaling pathway (GO:0038194) is a fundamental biological process with critical roles in thyroid development, metabolism, immunity, and intestinal homeostasis. Its dysregulation is implicated in thyroid cancer, autoimmune thyroiditis, colorectal carcinoma, and central hypothyroidism-associated intestinal dysplasia. Continued research using advanced CRISPR models and multi-omics approaches will further elucidate its mechanisms and therapeutic potential.
References
- 1. Zeng S et al.. 2024. Local TSH/TSHR signaling promotes CD8(+) T cell exhaustion and immune evasion in colorectal carcinoma.. Cancer Commun (Lond) 44(11):1287-1310 PMID: 39285586
- 2. Eszlinger M et al.. 2023. Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.. Eur Thyroid J 12(6) PMID: 37855416
- 3. Paparo SR et al.. 2022. Myoinositol in Autoimmune Thyroiditis.. Front Endocrinol (Lausanne) 13:930756 PMID: 35837308
- 4. Moulana FI et al.. 2018. BRAF-Oncogene-Induced Senescence and the Role of Thyroid-Stimulating Hormone Signaling in the Progression of Papillary Thyroid Carcinoma.. Horm Cancer 9(1):1-11 PMID: 29209896
- 5. Postiglione MP et al.. 2002. Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland.. Proc Natl Acad Sci U S A 99(24):15462-7 PMID: 12432093
- 6. Latif R et al.. 2009. The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling.. Endocrinol Metab Clin North Am 38(2):319-41, viii PMID: 19328414
- 7. Li Y et al.. 2017. Thyroid stimulating hormone increases hepatic gluconeogenesis via CRTC2.. Mol Cell Endocrinol 446:70-80 PMID: 28212844
- 8. Peng L et al.. 2024. Thyroid hormone deprival and TSH/TSHR signaling deficiency lead to central hypothyroidism-associated intestinal dysplasia.. Life Sci 345:122577 PMID: 38521387
